HAYLEY MATEEN: Open Payments
NPI 1982393492 · PEABODY, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$842 in 36 payments from 19 companies in 2025. Trend: 2023 $467 · 2024 $1,106 · 2025 $842
Food & beverage: $842
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 4 | $93 |
| HARMONY BIOSCIENCES LLC | 1 | $80 |
| ABBVIE INC. | 4 | $78 |
| Inspire Medical Systems, Inc. | 3 | $68 |
| Lilly USA, LLC | 3 | $67 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $64 |
| Lundbeck LLC | 3 | $64 |
| AstraZeneca Pharmaceuticals LP | 3 | $60 |
| Sumitomo Pharma America, Inc. | 2 | $38 |
| Dexcom, Inc. | 1 | $34 |
Products named: REXULTI, JARDIANCE, WAKIX, VRAYLAR, INSPIRE, BREZTRI, GEMTESA, Dexcom G6 Transmitter.
Industry payments across MA — which companies pay providers there.
